
### [NCIT:C8770](http://purl.obolibrary.org/obo/NCIT_C8770)
**Label:** Stage III Pharyngeal Cancer

**Subclasses:** [NCIT:C8219](http://purl.obolibrary.org/obo/NCIT_C8219) (Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C133007](http://purl.obolibrary.org/obo/NCIT_C133007) (Stage III Hypopharyngeal Carcinoma AJCC v8), [NCIT:C8227](http://purl.obolibrary.org/obo/NCIT_C8227) (Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8226](http://purl.obolibrary.org/obo/NCIT_C8226) (Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C8234](http://purl.obolibrary.org/obo/NCIT_C8234) (Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C7396](http://purl.obolibrary.org/obo/NCIT_C7396) (Stage III Nasopharyngeal Carcinoma AJCC v6), [NCIT:C88983](http://purl.obolibrary.org/obo/NCIT_C88983) (Stage III Nasopharyngeal Carcinoma AJCC v7), [NCIT:C8050](http://purl.obolibrary.org/obo/NCIT_C8050) (Stage III Oropharyngeal Carcinoma AJCC v6), [NCIT:C132819](http://purl.obolibrary.org/obo/NCIT_C132819) (Stage III Nasopharyngeal Carcinoma AJCC v8), [NCIT:C89046](http://purl.obolibrary.org/obo/NCIT_C89046) (Stage III Hypopharyngeal Carcinoma AJCC v7), [NCIT:C8040](http://purl.obolibrary.org/obo/NCIT_C8040) (Stage III Hypopharyngeal Carcinoma AJCC v6), [NCIT:C89021](http://purl.obolibrary.org/obo/NCIT_C89021) (Stage III Oropharyngeal Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C27970](http://purl.obolibrary.org/obo/NCIT_C27970) (Stage III) 53.57%
- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 38.93%


